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Abstract: One of the challenges to implementing sensitivity analysis for exposure 
misclassification is the process of specifying the classification proportions (eg, sensitivity and 
specificity). The specification of these assignments is guided by three sources of information: 
estimates from validation studies, expert judgment, and numerical constraints given the data. 
The purpose of this teaching paper is to describe the process of using validation data and expert 
judgment to adjust a breast cancer odds ratio for misclassification of family breast cancer 
history. The parameterization of various point estimates and prior distributions for sensitivity 
and specificity were guided by external validation data and expert judgment. We used both 
nonprobabilistic and probabilistic sensitivity analyses to investigate the dependence of the 
odds ratio estimate on the classification error. With our assumptions, a wider range of odds 
ratios adjusted for family breast cancer history misclassification resulted than portrayed in the 
conventional frequentist confidence interval.
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Introduction
A standard quantitative analysis of epidemiologic data implicitly assumes the exposure 
(risk marker, risk factor) classification proportions (eg, sensitivity and specificity) 
equal 1.0 (ie, perfect classification). For many studies, however, this assumption may 
not be justified. Epidemiologists are strongly encouraged to incorporate sensitivity 
analyses into the analysis for these situations.1–9
One of the challenges to implementing sensitivity analysis for exposure misclas-
sification of a binary exposure variable is the process of specifying the sensitivity and 
specificity values. The difficulty lies in determining which values should be used and 
explaining why these values were used. The specification of these values is guided 
by three sources of information: estimates from validation studies, expert judgment, 
and numerical constraints given the data.10
These three sources of information can be used in both nonprobabilistic and 
probabilistic (Monte-Carlo) sensitivity analysis. When adjusting for exposure 
misclassification, nonprobabilistic sensitivity analysis11 uses multiple fixed values 
for the sensitivity and specificity proportions. In contrast, in probabilistic sensitivity 
analysis,5,7,11–15 an investigator specifies probability distributions for the classification 
proportions. Prior probabilities are not specified for the effect measure of interest or 
the exposure prevalence; thus the analysis corresponds to using noninformative priors 
for these parameters in Bayesian bias analysis.7,11,16–18
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The goal of  this teaching paper is to illustrate how to specify 
values of classification parameters for nonprobabilistic11 and 
probabilistic sensitivity analyses5,7,11–15 using two of the three 
sources of information: validation data and expert judgment. 
We will specify single-point estimates and probability 
distributions for classification parameters. Then we will use 
these estimates and distributions to adjust one odds ratio (OR) 
estimate for possible exposure misclassification.
Application
For many types of cancer, an important predictor of a 
person’s cancer risk is an established family history of that 
cancer. While accurate reporting by affected relatives might 
be expected, in fact, validation studies have shown that self-
reported history of cancer in family members is inaccurately 
reported.19–21
Epidemiologic studies that rely on these self-reports of 
cancer in family members without adjustment for classification 
errors can provide inaccurate results and underestimates of 
the true uncertainty. Adjusting relative-risk estimates for 
systematic error under such circumstances (eg, exposure 
misclassification) has been strongly encouraged.1–8,11,22,23
We selected breast cancer as our example because it is 
both prevalent and because a family history of breast cancer 
is an established predictor of breast cancer risk. We chose 
one case-control study24 that provided a 2 × 2 table of 
first-degree relative’s (FDR’s) breast cancer history and 
breast cancer risk. There were 316 exposed breast cancer 
cases, 1567 unexposed cases, 179 exposed noncases, and 
1449 unexposed noncases, where exposure was any FDR’s 
breast cancer history. From these data, the calculated crude 
OR estimate associating FDR with breast cancer occurrence 
for women from Los Angeles County, California, was 1.63 
(95% confidence limits: 1.34, 1.99). The OR adjusted for 
confounders was 1.68.
Methods
Source 1:  Validation data
Identifying validation studies
The observed exposure measure was self-reported breast 
cancer history in any FDR – a parent, sibling or child – by the 
index subject. “Gold standard” measurements used to verify 
the breast cancer status in FDRs were verbal confirmation 
by the FDR, medical records, pathology reports, cancer 
registries, and/or death certificates. While these are labeled 
“gold standard,” they are themselves likely measured with 
some error. We defined sensitivity as the proportion of FDRs 
reported as having breast cancer among those according to the 
gold-standard measurement, and specificity as the proportion 
of FDRs not reported as having breast cancer given it was 
absent from the gold standard measurement at the time of 
index subject’s interview.
With these criteria, we sought out articles that validated 
self-reported data on any FDR. Our approach was guided by 
a 2004 article by Murff and colleagues19 that summarized the 
results from validation studies that determined the accuracy 
of self-reported history of cancer in family members for 
colon, prostate, breast, endometrial, and ovarian cancers. The 
first author met with a research librarian for search-strategy 
assistance since medical subject headings change over 
time. In April 2008, after discussions with a librarian, AMJ 
performed a database literature search to find English-
language articles that provided sensitivity and specificity 
values for classification of self-reported family breast 
cancer history. The following medical subject headings from 
PubMed were used: “sensitivity and specificity”, “breast 
neoplasms”, “reproducibility of results”, and “medical 
history taking”. A text-word search for “validation study” 
as well as the above terms was also performed. Article titles, 
abstracts, and text were reviewed for inclusion. Reference 
lists of identified articles were searched to identify additional 
studies.
We also performed a cited-reference search of the Murff 
and colleagues19 article to learn whether it was referenced 
in recently published studies. Studies that determined 
accuracy (eg, positive-predictive value) of family breast 
cancer history,25–29 expanded first-degree relatives to include 
aunts,30 did not distinguish between FDRs and second-degree 
relatives,31 validated bilateral breast cancer,32 or were a 
sub-study of a larger included validation study33 were not 
used. Five publications20,21,34–36 met our criteria.
Incorporating validation data
We assumed the data from the five validation studies 
(Table 1) to be appropriate for adjusting the OR for misclas-
sification. Using these data, we explored various scenarios 
for possible classification error. The scenarios involved 
differential classification error because the validation 
data (Table 1) indicated the classification processes were 
differential.
For nonprobabilistic sensitivity analysis
We specified single-point values as scenarios for possible 
classification proportions. Since Kerber and Slattery34 
reported classification proportions for both cases and 
noncases (Table 1), we considered this validation study as one 
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scenario (scenario 2, Table 2). Then we combined the noncase 
sensitivity and specificity values from Chang and colleagues20 
with the breast cancer case sensitivity and specificity 
values from Verkooijen and colleagues35 and Ziogas and 
Anton-Culver36 for scenarios 3 and 4 (Table 2), respectively. 
Similarly, we combined the noncase classification propor-
tions from Soegaard and colleagues21 with case classification 
proportions from Verkooijen and colleagues35 and Ziogas and 
Anton-Culver36 for scenarios 5 and 6 (Table 2), respectively. 
We also defined scenarios for the lower (scenario 7, 
Table 2) and upper (scenario 8, Table 2) extreme values 
from all five studies. Finally, we investigated a scenario 
within the ranges of validation data (scenario 9, Table 2) 
and other combinations from the validation data (scenarios 
10 and 11, Table 2).
For probabilistic sensitivity analysis
To assign probability distributions to the classification 
parameters, we examined each column of sensitivity 
and specificity data in Table 1 for cases and noncases 
separately. Although we assumed the ranges of validation 
data to be adequate for our probability distributions, we 
were not 100% confident in the distributions’ shapes. As a 
result, we constructed different distribution scenarios to 
determine the dependence classification error had on the 
crude OR.
Table 1 Validation studies that reported sensitivity and specificity values for self-reported first-degree relative’s breast cancer history
Breast cancer cases Healthy noncases
 
 
Authors
Sensitivity  
(No./Total)  
(95% CI)
Specificity 
(No./Total) 
(95% CI)
Sensitivity  
(No./Total)  
(95% CI)
Specificity  
(No./Total)  
(95% CI)
 
Source 
population
“Gold standard”  
measurement  
tool(s)
Chang et al20 – – 0.72 (61/85) 
(0.62, 0.81)
0.99 (1114/1127) 
(0.98, 0.99)
Sweden Swedish Cancer Registry
Kerber and 
Slattery34
0.85 (11/13) 
(0.55, 0.98)
0.96 (107/112) 
(0.90, 0.99)
0.82 (18/22) 
(0.60, 0.95)
0.91 (167/184) 
(0.87, 0.95)
Utah, USA Utah Population  
Database
Soegaard et al21 – – 0.94 (121/129) 
(0.90, 0.98)
1.00 (4505/4527) 
(0.99, 1.00 )
Denmark Danish Cancer Registry
Verkooijen 
et al35
0.98 (60/61) 
(0.91, 1.00)
0.99 (247/249) 
(0.97, 1.00)
– – Geneva, 
Switzerland
Cantonal Population 
Office and Geneva 
Cancer Registry
Ziogas and 
Anton-Culver36
0.95 (188/197) 
(0.93, 0.98)
0.97 (850/873) 
(0.96, 0.98)
– – Orange County, 
California, USA
Pathology, self-reported, 
or death certificates
Abbreviation: CI, confidence interval.
Table 2 Single point-estimate values for classification errors and nonprobabilistic sensitivity analysis results
Breast cancer cases Healthy noncases
Scenario Sensitivity Specificity Sensitivity Specificity ORadjusted
1a 1.00 1.00 1.00 1.00 1.63
2 0.85 0.96 0.82 0.91 6.67
3 0.98 0.99 0.72 0.99 1.19
4 0.95 0.97 0.72 0.99 1.08
5 0.98 0.99 0.94 1.00 1.46
6 0.95 0.97 0.94 1.00 1.33
7 0.85 0.96 0.72 0.91 5.73
8 0.98 0.99 0.94 1.00 1.47
9b 0.92 0.98 0.93 0.99 1.61
10 0.98 0.96 0.72 1.00 0.87
11 0.85 0.99 0.94 0.91 9.62
Notes: aCrude odds ratio scenario;  bApproximately nondifferential.
Abbreviation: ORadjusted, odds ratio adjusted for family breast cancer history (exposure) misclassification.
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To allow each value within the range an equal probability 
of occurring, we began by specifying continuous uniform 
distributions informed by the lower and upper values of 
the validation data values (scenario 13, Table 3). Since the 
case and noncase classification proportions each had three 
values, triangular distributions were then used for both 
cases and noncases (scenarios 14 and 15, Table 3). That is, 
we specified triangular distributions using the lower and 
upper validation data values as the minimum and maximum, 
respectively, and the middle value (scenario 14) and average 
value (scenario 15) as the modes for each distribution.
Source 2: Incorporating expert 
knowledge
We changed the upper limit to 1.00 (perfect sensitivity and 
specificity) in scenarios 13–15 (Table 3), because we cannot 
rule out the possibility that all individuals with and without 
breast cancer may be correctly classified.
Source 3: Incorporating numerical 
constraints given the data
Adjustment for misclassification may result in negative cell 
frequencies when certain combinations of observed data 
and classification proportions are used. However, negative 
cell frequencies are impossible. Therefore, combinations 
of values yielding negative corrected cell frequencies are 
impossible and should be excluded from the sensitivity 
analysis. In our sensitivity analyses, no combinations of 
values assigned to sensitivity and specificity resulted in 
adjusted-cell frequencies that were negative. Therefore, 
no values were excluded within the explored ranges of 
values.
Nonprobabilistic sensitivity analyses
For each of the 11 scenarios (Table 2), we calculated an OR 
adjusted for family breast cancer history misclassification 
(OR
adjusted
) using the exposure misclassification adjustment 
methods of Greenland and Lash.11 Briefly, we used the 
observed cell frequencies of data along with sensitivity and 
specificity values for cases and noncases (Table 1) to calcu-
late a 2 × 2 table of cell frequencies adjusted for exposure 
misclassification and an odds ratio adjusted for exposure 
misclassification (Table 4).
Probabilistic sensitivity analyses
We employed probabilistic sensitivity analysis based 
on published methods.5,11,37 In short, we used equations 
in Table 4 to adjust the observed cell frequencies for 
exposure misclassification and substituted the probability 
distributions from Table 3 for the sensitivity and specificity 
values. We also included a correlation11,37 value of 0.80 
between the sensitivities for cases and noncases and between 
the specificities for cases and noncases to prevent extreme 
differentiality on any particular simulation trial. As a last 
step, we incorporated random error to obtain an OR estimate 
adjusted for exposure misclassification and random error. 
Adjustment for random error requires specification of a 
random error distribution for the data-generating process.38 
We used the following formula, exp ( )In OR z SEadjusted -  , 
which assumes that random error is modeled by a standard 
normal deviate (z) and the standard error (SE) of the original 
(misclassified) cell frequencies.11,22,23
For each scenario, we graphed a frequency (uncertainty) 
distribution of the odds ratio adjusted for exposure misclas-
sification only and for exposure misclassification and random 
error. These frequency distributions are dependent on our 
assumptions for the classification proportions and random 
error parameters. We also calculated 95% uncertainty limits 
by taking the lower 2.5 and upper 97.5 percentiles of the 
frequency distribution. These percentiles provide the lower 
and upper limits for the odd ratio adjusted for our beliefs 
about the relative proportions of the exposure-classification 
Table 3 Descriptions of the probability distributions used for exposure classification errors
Breast cancer cases Healthy noncases
 Scenario Sensitivity Specificity Sensitivity Specificity
12 Custom uniforma (1.00) Custom uniform (1.00) Custom uniform (1.00) Custom uniform (1.00)
13 Uniformb (0.85, 1.00) Uniform (0.96, 1.00) Uniform (0.72, 1.00) Uniform (0.91, 1.00)
14 Triangularc (0.85, 0.95, 1.00) Triangular (0.96, 0.97, 1.00) Triangular (0.72, 0.82, 1.00) Triangular (0.91, 0.99, 1.00)
15 Triangular (0.85, 0.93, 1.00) Triangular (0.96, 0.97, 1.00) Triangular (0.72, 0.83, 1.00) Triangular (0.91, 0.97, 1.00)
Notes: aDiscrete uniform distribution with a single value at 1.00 with probability of occurring = 1; bContinuous uniform distribution (minimum value, maximum value); 
cTriangular distribution (minimum value, mode, maximum value).
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values (ie, uncertainty-analysis-parameter values).8 Crystal 
Ball (version 7.3; Oracle, Redwood Shores, CA, USA) 
software was used to run 50,000 simulation trials for the four 
simulation experiments.
Results
Table 2 presents the results of the nonprobabilistic sensitivity 
analyses. The OR adjusted for misclassification resulted 
in a wide range of values, assuming the OR adjusted 
for misclassification is the true value, our assumptions 
are correct, and no other systematic errors exist. Some 
combinations of classification proportions (scenarios 2, 7, 
and 11, Table 2) gave ORs adjusted for misclassification 
that were much greater than the crude OR of 1.63, other 
combinations resulted in ORs between 1 and the crude OR 
(scenarios 3–6, 8, and 9, Table 2), and one combination 
produced a protective effect (scenario 10, Table 2). Thus, 
demonstrating that differential classification error can 
cause error toward (scenarios 2, 7, and 11, Table 2), away 
from (scenarios 3–6, 8, and 9), or past the null value of 1 
(scenario 10, Table 2).39 Approximately nondifferential 
misclassification (scenario 9, Table 2) resulted in an OR 
adjusted for exposure misclassification that was less than 
the crude value.
The probabilistic sensitivity analyses results are found 
in Table 5 and Figures 1 and 2. The geometric means and 
medians are greater than the crude OR value of 1.63 for 
scenarios where classification was imperfect, and over 
Table 4 2 × 2 tablea after adjustment for exposure misclassification
Breast cancer outcome
Any first-degree family breast cancer history Odds ratio adjusted for 
exposure misclassificationYes No
Breast cancer cases
e
a Sp a b
Se Sp
cases
cases cases
=
- - +
+ -
( )( )1
1
f = a + b - e
OR
e h
f g
adjusted =
⋅
⋅
Breast cancer noncases
g
c Sp c d
Se Sp
noncases
noncases noncases
=
- - +
+ -
( )( )1
1
h = c + d - g
Notes: aa, breast cancer cases classified as having a first-degree family breast cancer history; b, breast cancer cases classified as not having a first-degree family breast cancer 
history; c, breast cancer noncases classified as having a first-degree family breast cancer history; d, breast cancer noncases classified as not having a first-degree family breast 
cancer history;
Abbreviations: OR, odds ratio; Se, sensitivity; Sp, specificity.
Table 5 Probabilistic sensitivity analyses resultsa after 50,000 simulation trials, by scenario
 
 
Scenario
 
 
Analysis
ORadjusted 
geometric 
mean
 
ORadjusted 
median
95% uncertainty 
limits for  
ORadjusted
% of trials with  
ORadjusted  crude 
ORb
Ratio of upper 95% 
uncertainty limit to lower 
95% uncertainty limit
12c a. No misclassification 1.63 1.63 (1.63, 1.63) 0 1.00
b. Conventional analysis 
(random error only)
1.63 1.63 (1.34, 1.99) 50.6 1.49
13 a. Misclassification only 2.46 2.25 (1.41, 5.88) 84.4 4.17
b. Misclassification and 
random error
2.46 2.27 (1.33, 6.01) 83.3 4.52
14 a. Misclassification only 1.89 1.74 (1.36, 3.84) 62.5 2.82
b. Misclassification and 
random error
1.89 1.77 (1.25, 3.93) 64.0 3.14
15 a. Misclassification only 2.09 1.96 (1.46, 4.13) 85.0 2.83
b. Misclassification and 
random error
2.09 1.99 (1.37, 4.21) 81.8 3.07
Notes: aCorrelation between the sensitivities for cases and noncases and between the specificities for cases and noncases = 0.80; bCrude odds ratio = 1.63; cCrude odds 
ratio scenario.
Abbreviation: ORadjusted, Odds ratio adjusted for family breast cancer history (exposure) misclassification.
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Figure 1 Frequency distributions of breast cancer odds ratios adjusted for family breast cancer history misclassification, by scenario.
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Figure 2 Frequency distributions of breast cancer odds ratios adjusted for family breast cancer history misclassification and random error, by scenario.
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half of the simulation trials resulted in ORs adjusted for 
exposure misclassification greater than the crude OR. The 
95% uncertainty limits are wider than the conventional 
limits (1.34, 1.99). Compared to the conventional analysis 
(scenario 12, analysis b, Table 5), the ratio of the upper 
95% uncertainty limit to the 95% lower uncertainty limit 
was largest for the uniform scenario (scenario 13, analysis 
b, Table 5). Minor changes in the modal values shifted the 
distribution of ORs adjusted for exposure misclassification 
further away from the crude OR for scenario 15 compared 
with scenario 14 because scenario 15 is slightly more 
differential than scenario 14.
Discussion
We performed partial sensitivity analyses to adjust a breast 
cancer OR estimate for misclassification of family breast 
cancer history. In general, three sources10 of information are 
used to specify scenarios for sensitivity analysis: validation 
data (we found existing data in the literature20,21,34–36); expert 
judgment (we modified ranges of values from the validation 
studies based on our expert judgment of sensitivity 
and specificity for family history of breast cancer); and 
numerical constraints given the data (we were prepared 
to exclude values assigned to classification proportions 
that yielded negative cell frequencies). For all sensitivity 
analyses we further assumed that the OR estimate adjusted 
for exposure misclassification was not affected by other 
systematic errors.
We used both nonprobabilistic and probabilistic sensitivity 
analyses because they are complementary yet imperfect 
techniques. Since no likelihood (probability) is associated 
explicitly with each scenario in the nonprobabilistic 
sensitivity analysis, the results should not necessarily be 
viewed as having equal probability. The nonprobabilistic 
sensitivity analyses resulted in a wide range of ORs adjusted 
for exposure misclassification: from less than 1 to almost six 
times the crude OR value. Similar results were found using 
probabilistic sensitivity analyses.
As guided by the literature, classification errors were 
differential for all scenarios. It is well known that the 
effect of differential misclassification on study results is 
unpredictable. Both our nonprobabilistic and probabilistic 
sensitivity analysis results show the wide range of values 
that are possible. Importantly, approximately nondifferential 
misclassification resulted in an OR adjusted for 
misclassification that was less than the crude (Table 2, 
scenario 9). Thus, the sensitivity analysis results demonstrate 
the importance of quantitatively evaluating the effect of 
differential misclassification. Nevertheless, nondifferential 
misclassification only biases the expected value of an 
OR estimate toward the null value under very specific 
conditions.39
When available, internal validation data from the study of 
interest are the recommended data to inform the values used 
for sensitivity analysis, so long as the internal validation study 
itself was not biased by, for example, selection of subjects 
into the validation substudy. When such unbiased validation 
data are available, we specify sampling-error distributions 
for the classification probabilities observed in the validation 
substudy. Since we did not have internal validation data for 
the sensitivities and specificities from the study of interest,24 
we could not use this approach.
We were able to find external validation data to inform 
the values assigned to classification proportions in our 
sensitivity analyses. The validation data, however, were 
not generated from the same population as that from the 
crude OR data. Therefore, these external validation data 
may not be generalizable across different populations. 
Further, the classification proportions were not calculated 
by first-degree relative status (eg, grandmother, sister, and 
daughter), which may differ by generation. Nonetheless, 
we know of no existing methodology that incorporates 
selection forces into the classification proportions for 
sensitivity analyses.
When only external validation data for the classification 
proportion estimates are available, it is difficult to know which 
of these estimates to use. Therefore, we varied our probability 
distributions by specifying several different distributions. 
In addition, it is not recommended to pool the results from 
multiple-validation studies or to use the variance of the pooled 
result to parameterize a distribution. Instead, it is usually 
better to use the range of classification proportion values to 
parameterize a probability distribution (eg, triangular) or to 
use the range of values to conduct a multidimensional bias 
analysis. Further, we did not specify a probability distribution 
for each classification probability reported in external 
validation studies (a complete sensitivity analysis that takes 
into account the uncertainty in the classification proportions 
is the best route for funded analyses). Rather, we used the 
reported classification proportions to construct one composite 
probability distribution for each scenario.
The specification of the shape and range of the probability 
distribution is often difficult in light of internal or external 
validation data. In this research, we specified one uniform 
and two triangular distributions out of an infinite number 
of possibilities. Other probability distributions that can be 
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used include the trapezoidal, logit-normal, logit-logistic, 
and beta.11,14
When validation data are unavailable or inapplicable, 
investigators must assign values to the classification 
parameters based on expert judgment and numerical 
constraints given the data. This option, while perhaps 
suboptimal, has two advantages over conventional analyses 
that ignore quantitative estimates of uncertainty from 
classification errors. First, it emphasizes the absence of 
reliable validation data and identifies that absence as 
a research gap that should be a priority to fill. Second, 
conventional analyses implicitly treat the classification 
as perfect, and substituting expert judgment about actual 
classification errors for this often untenable assumption at 
least allows a quantitative assessment of the uncertainty 
arising from these errors.
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